These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts. Kohler TR; Kaufman JL; Kacoyanis G; Clowes A; Donaldson MC; Kelly E; Skillman J; Couch NP; Whittemore AD; Mannick JA Surgery; 1984 Sep; 96(3):462-6. PubMed ID: 6474351 [TBL] [Abstract][Full Text] [Related]
10. Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences. Bourassa MG; Fisher LD; Campeau L; Gillespie MJ; McConney M; Lespérance J Circulation; 1985 Dec; 72(6 Pt 2):V71-8. PubMed ID: 3905060 [TBL] [Abstract][Full Text] [Related]
11. Patterns of patency of 596 vein grafts up to seven years after aorta-coronary bypass. Lawrie GM; Morris GC; Chapman DW; Winters WL; Lie JT J Thorac Cardiovasc Surg; 1977 Mar; 73(3):443-8. PubMed ID: 320398 [TBL] [Abstract][Full Text] [Related]
12. [Comparative study of anticoagulant management after coronary artery bypass surgery--warfarin versus dipyridamole]. Yamaguchi A; Kitamura N; Miki T; Tatebayashi T; Kawashima M; Otaki M; Tamura H Nihon Kyobu Geka Gakkai Zasshi; 1992 Apr; 40(4):485-9. PubMed ID: 1613273 [TBL] [Abstract][Full Text] [Related]
13. [Permeability of aortocoronary bypass after 6 months. A multicenter French study]. Ollivier JP Arch Mal Coeur Vaiss; 1991 Apr; 84(4):537-42. PubMed ID: 2064515 [TBL] [Abstract][Full Text] [Related]
14. The effect of antithrombotic therapy on patency rates of saphenous vein coronary artery bypass grafts. McEnany MT; Salzman EW; Mundth ED; DeSanctis RW; Harthorne JW; Weintraub RM; Gates S; Austen WG J Thorac Cardiovasc Surg; 1982 Jan; 83(1):81-9. PubMed ID: 7033673 [TBL] [Abstract][Full Text] [Related]
15. [How long should antithrombotic therapy be continued following aortocoronary bypass surgery?]. Pfisterer M; Jockers G; Regenass S; Schmitt HE; Grädel E; Burkart F Schweiz Med Wochenschr; 1989 Oct; 119(43):1518-20. PubMed ID: 2692145 [TBL] [Abstract][Full Text] [Related]
16. Improvement of aortocoronary bypass patency by antiplatelet drug administration. Preliminary communication. Pirk J; Vojácek J; Kovác J Cor Vasa; 1986; 28(3):177-80. PubMed ID: 3527555 [TBL] [Abstract][Full Text] [Related]
17. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. Schwartz L; Bourassa MG; Lespérance J; Aldridge HE; Kazim F; Salvatori VA; Henderson M; Bonan R; David PR N Engl J Med; 1988 Jun; 318(26):1714-9. PubMed ID: 2967433 [TBL] [Abstract][Full Text] [Related]
18. Factors influencing 1-year patency of coronary artery saphenous vein grafts. Studio Indobufene nel Bypass Aortocoronarico (SINBA). Cataldo G; Braga M; Pirotta N; Lavezzari M; Rovelli F; Marubini E Circulation; 1993 Nov; 88(5 Pt 2):II93-8. PubMed ID: 8222202 [TBL] [Abstract][Full Text] [Related]
19. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study. Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Doherty J; Read R; Chesler E; Sako Y Circulation; 1989 Nov; 80(5):1190-7. PubMed ID: 2680158 [TBL] [Abstract][Full Text] [Related]
20. Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion. Pfisterer M; Burkart F; Jockers G; Meyer B; Regenass S; Burckhardt D; Schmitt HE; Müller-Brand J; Skarvan K; Stulz P Lancet; 1989 Jul; 2(8653):1-7. PubMed ID: 2567792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]